NF-κB as a target for oncogenic viruses

Current Topics in Microbiology and Immunology

Volumn 349, Issue , 2011, Pages 197-244

  Sun, Shao Cong ^a   Cesarman, Ethel ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; ONCOPROTEIN; TAX PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BURKITT LYMPHOMA; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; ENZYME MECHANISM; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOCOMPETENCE; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LIFE CYCLE STAGE; LYMPHOCYTE TRANSFORMATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; NONHUMAN; PLASMABLASTIC LYMPHOMA; POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TUMOR VIRUS; UBIQUITINATION; VIRUS ATTACHMENT; VIRUS CARCINOGENESIS; VIRUS ENTRY; VIRUS REACTIVATION; ANIMAL; PHYSIOLOGY; REVIEW;

HUMAN HERPESVIRUS 8; HUMAN T-LYMPHOTROPIC VIRUS 1;

ANIMALS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; SIGNAL TRANSDUCTION;

EID: 84859991707     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-108     Document Type: Article

References (290)

1. Adhikari A, Xu M, Chen ZJ (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26:3214-3226 (Pubitemid 46763016)
2. Ariza ME, Glaser R, Kaumaya PT, Jones C, Williams MV (2009) The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182:851-859
3. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL (2008) Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 112:3788-3797
4. Arvanitakis L, Mesri EA, Nador R, Said JW, Asch AS, Knowles DM, Cesarman E (1996) Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88:2648-2654 (Pubitemid 26327517)
5. Babcock GJ, Hochberg D, Thorley-Lawson AD (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506
6. Babu G, Waterfield M, Chang M, Wu X, Sun S-C (2006) Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells. J Biol Chem 281:14041-14047 (Pubitemid 43848330)
7. Bagneris C, Ageichik AV, Cronin N, Wallace B, Collins M, Boshoff C, Waksman G, Barrett T (2008) Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol Cell 30:620-631 (Pubitemid 351755065)
8. Baldwin A S Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683 (Pubitemid 26130197)
9. Beinke S, Ley SC (2004) Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382:393-409 (Pubitemid 39243905)
10. Béraud C, Sun S-C, Ganchi PA, Ballard DW, Greene WC (1994) Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-κB2 p100 gene product: implications for viral latency. Mol Cell Biol 14:1374-1382 (Pubitemid 24036587)
11. Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC (2007) X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J Virol 81:7363-7370 (Pubitemid 47047825)
12. Boshoff C, Weiss RA (1998) Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res 75:57-86 (Pubitemid 28429033)
13. Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y (1998) Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91:1671-1679 (Pubitemid 28110332)
14. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10:321-322
15. Brielmeier M, Mautner J, Laux G, Hammerschmidt W (1996) The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J Gen Virol 77(Pt 11):2807-2818 (Pubitemid 26390582)
16. Brousset P, Cesarman E, Meggetto F, Lamant L, Delsol G (2001) Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease. Hum Pathol 32:95-100 (Pubitemid 32150634)
17. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R (2003) NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77:8532-8540 (Pubitemid 36871481)
18. Burmeister T (2001) Oncogenic retroviruses in animals and humans. Rev Med Virol 11:369-380 (Pubitemid 34024255)
19. Cahir McFarland ED, Izumi KM, Mosialos G (1999) Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18:6959-6964
20. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97:6055-6060 (Pubitemid 30367522)
21. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E (2004) Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 78:4108-4119 (Pubitemid 38437217)
22. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102:5570-5575 (Pubitemid 40530298)
23. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405-411 (Pubitemid 28462761)
24. Caldwell RG, Brown RC, Longnecker R (2000) Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol 74:1101-1113 (Pubitemid 30044059)
25. Cannon ML, Cesarman E (2004) The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 23:514-523 (Pubitemid 38175006)
26. Cannon JS, Nicholas J, Orenstein JM, Mann RB, Murray PG, Browning PJ, DiGiuseppe JA, Cesarman E, Hayward GS, Ambinder RF (1999) Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 180:824-828 (Pubitemid 29411370)
27. Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GS, Ambinder RF (2000) A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 74:10187-10193
28. Cannon M, Cesarman E, Boshoff C (2006) KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood 107:277-284 (Pubitemid 43053552)
29. Carbone A (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4:22-29 (Pubitemid 36124187)
30. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, Antinori A, Tirelli U, Falini B, Dalla-Favera R (1998) Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91:747-755 (Pubitemid 28078274)
31. Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, Tirelli U (2005) Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 7:17-27 (Pubitemid 40310161)
32. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF (2009) HIV-associated lymphomas and gamma-herpesviruses. Blood 113:1213-1224
33. Carter RS, Pennington KN, Ungurait BJ, Arrate P, Ballard DW (2003) Signal-induced ubiquitination of I kappaB kinase-beta. J Biol Chem 278:48903-48906
34. Carter RS, Pennington KN, Arrate P, Oltz EM, Ballard DW (2005) Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation. J Biol Chem 280:43272-43279 (Pubitemid 43049294)
35. Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R, Franchini G, Klotman ME (1996) p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood 88:1551-1560 (Pubitemid 26307048)
36. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995a) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 332:1186-1191
37. Cesarman E, Moore PS, Rao P, Inghirami G, Knowles DM, Chang Y (1995b) In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesviruslike (KSHV) DNA sequences. Blood 86:2708-2714
38. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM (2004) KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28:1401-1416 (Pubitemid 39425507)
39. Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ (2002) Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94:1614-1619 (Pubitemid 35378726)
40. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869
41. Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK, Varshavsky A (1989) A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243:1576-1583 (Pubitemid 19090506)
42. Chaudhary PM, Jasmin A, Eby MT, Hood L (1999a) Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18:5738-5746 (Pubitemid 29507427)
43. Chaudhary PM, Jasmin A, Eby MT, Hood L (1999b) Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 14:5738-5746 (Pubitemid 29507427)
44. Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758-765
45. Chen G, Cao P, Goeddel DV (2002a) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9:401-410 (Pubitemid 34195564)
46. Chen SY, Lu J, Shih YC, Tsai CH (2002b) Epstein-Barr virus latent membrane protein 2A regulates c-Jun. protein through extracellular signal-regulated kinase. J Virol 76:9556-9561 (Pubitemid 34919914)
47. Chen ZJ, Bhoj V, Seth RB (2006) Ubiquitin, TAK1 and IKK: is there a connection? Cell Death Differ 13:687-692
48. Chu Z-L, DiDonato JA, Hawiger J, Ballard DW (1998) The Tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ. J Biol Chem 273:15891-15894 (Pubitemid 28311350)
49. Chu Z-L, Shin Y-A, Yang J-M, DiDonato JA, Ballard DW (1999) IKKγ mediates the interaction of cellular IκB kinases with the Tax transforming protein of human T cell leukemia virus type 1. J Biol Chem 274:15297-15300
50. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, Richardson JA, Smith AL, Chaudhary PM (2005) Constitutive NF-{kappa}B activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci USA 102:12885-12890 (Pubitemid 41279459)
51. Claudio E, Brown K, Park S, Wang H, Siebenlist U (2002) BAFF-induced NEMO-independent processing of NF-kappaB2 in maturing B cells. Nat Immunol 3:958-965 (Pubitemid 35154010)
52. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC (2002) CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 15:5375-5385 (Pubitemid 35231017)
53. Coornaert B, Carpentier I, Beyaert R (2009) A20: central gatekeeper in inflammation and immunity. J Biol Chem 284:8217-8221
54. Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ (1987) Regulation of the human interleukin-2 receptor a chain promoter: activation of a non functional promoter by the transactivator gene of HTLV-1. Cell 49:47-56
55. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM (2006) Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354:2431-2442 (Pubitemid 43855046)
56. Dawson CW, George JH, Blake SM, Longnecker R, Young LS (2001) The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1. Virology 289:192-207 (Pubitemid 33140999)
57. de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F (2000) Gene expression array of HTLV type 1-infected T cells: up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses 16:1695-1700
58. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535 (Pubitemid 35223540)
59. Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST (2005) High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 19:851-855 (Pubitemid 40663108)
60. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72:8309-8315 (Pubitemid 28421829)
61. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A (1999) The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 190:1025-1032 (see comments)
62. Dong J, Zhong H, Hayden MS, Ghosh G (2008) Repression of gene expression by unphosphorylated NF-κB p65 through epigenetic mechanisms. Genes Dev 22:1159-1173 (Pubitemid 351656576)
63. Doxsey S, McCollum D, Theurkauf W (2005) Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 21:411-434 (Pubitemid 41740641)
64. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97:2130-2136 (Pubitemid 32239096)
65. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG (2002) KSHV-and EBV-associated germinotropic lymphoproliferative disorder. Blood 100:3415-3418 (Pubitemid 35217095)
66. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546-4551 (Pubitemid 29190373)
67. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406-1412 (Pubitemid 30099854)
68. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006) Activation of IKK by TNFalpha requires sitespecific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22:245-257
69. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, Jaffe ES (1998) Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11:754-761 (Pubitemid 28381610)
70. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 94:1204-1210 (Pubitemid 34993870)
71. Engels EA, Pittaluga S, Whitby D, Rabkin C, Aoki Y, Jaffe ES, Goedert JJ (2003) Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 16:424-429 (Pubitemid 36618462)
72. Feuer G, Green PL (2005) Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24:5996-6004 (Pubitemid 43086117)
73. Feuillard J, Schuhmacher M, Kohanna S, Asso-Bonnet M, Ledeur F, Joubert-Caron R, Bissieres P, Polack A, Bornkamm GW, Raphael M (2000) Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 95:2068-2075 (Pubitemid 30151647)
74. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116:3721-3728 (Pubitemid 37185301)
75. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E (1998) Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592 (Pubitemid 28366835)
76. Franchini G, Nicot C, Johnson JM (2003) Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res 89:69-132 (Pubitemid 41184280)
77. Fruehling S, Longnecker R (1997) The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251 (Pubitemid 27394337)
78. Fukuda M, Longnecker R (2007) Epstein-Barr virus (EBV) Latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol 81:9299-9306 (Pubitemid 47311472)
79. Fukuda RI, Tsuchiya K, Suzuki K, Itoh K, Fujita J, Utsunomiya A, Tsuji T (2009) Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3, 4, 5-trisphosphate inositol phosphatases via the NF-kappaB pathway. J Biol Chem 284:2680-2689
80. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, Bron C, Tschopp J, Thome M (2002) CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 3:836-843
81. Gartenhaus RB, Wang P (1995) Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia 9:2082-2086 (Pubitemid 26023793)
82. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham E T Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC (1998) Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IkB kinase α (IKKα) and IKKβ cellular kinases. Mol Cell Biol 18:5157-5165 (Pubitemid 28388099)
83. Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16:6131-6140 (Pubitemid 27458333)
84. Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C (2005) Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105:2510-2518 (Pubitemid 40387053)
85. Grassmann R, Dengler C, Müller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar M-C, Sodroski JG, Haseltine WA (1989) Transformation to continuous growth of primary human T-lymphocytes by human T-cell leukemia virus type I X-region gene transduced by a herpesvirus saimiri vector. Proc Natl Acad Sci USA 86:3351-3355 (Pubitemid 19129609)
86. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U (1992) Role of human T-cell leukemia virus type I x region proteins in immortalization of primary human lymphocytes in culture. J Virol 66:4570-4575
87. Guasparri I, Keller SA, Cesarman E (2004) KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993-1003 (Pubitemid 38481090)
88. Guasparri I, Wu H, Cesarman E (2006) The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep 7:114-119
89. Guasparri I, Bubman D, Cesarman E (2008) EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111:3813-3820
90. Hall PA, Donaghy M, Cotter FE, Stansfeld AG, Levison DA (1989) An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 14:333-346 (discussion 429-432) (Pubitemid 19129375)
91. Hara H, Bakal C, Wada T, Bouchard D, Rottapel R, Saito T, Penninger JM (2004) The molecular adapter Carma1 controls entry of IkappaB kinase into the central immune synapse. J Exp Med 200:1167-1177 (Pubitemid 39507056)
92. Harhaj EW, Sun S-C (1999) IKKg serves as a docking subunit of the IkB kinase and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274:22911-22914
93. Harhaj EW, Good L, Xiao G, Sun S-C (1999) Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 18:1341-1349 (Pubitemid 29094886)
94. Harhaj NS, Sun SC, Harhaj EW (2007) Activation of NF-kappa B by the human T cell leukemia virus type I (HTLV-I) tax oncoprotein is associated with ubiquitin-dependent relocalization of IKK. J Biol Chem 282:4185-4192 (Pubitemid 47084492)
95. Harris NL (1998) The many faces of Hodgkin's disease around the world: what have we learned from its pathology? Ann Oncol 9:S45-S56 (Pubitemid 29049117)
96. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12:466-472
97. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344-362
98. Higuchi M, Tsubata C, Kondo R, Yoshida S, Takahashi M, Oie M, Tanaka Y, Mahieux R, Matsuoka M, Fujii M (2007) Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line. J Virol 81:11900-11907 (Pubitemid 47623821)
99. Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S (2004) Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 6:266-278 (Pubitemid 38657083)
100. Ho JW, Ho FC, Chan AC, Liang RH, Srivastava G (1998) Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 185:79-85 (Pubitemid 28266720)
101. Homig-Holzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Muller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U (2008) Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med 205:1317-1329 (Pubitemid 351831489)
102. Horie R (2007) NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma. Int Rev Immunol 26:269-281 (Pubitemid 350131623)
103. Huang GJ, Zhang ZQ, Jin DY (2002) Stimulation of IKK-gamma oligomerization by the human T-cell leukemia virus oncoprotein Tax. FEBS Lett 531:494-498
104. Huang J, Ren T, Guan H, Jiang Y, Cheng H (2009) HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J Biol Chem 284:6208-6217
105. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kuhn M, Lenze D, Lichter P, Martin-Subero JI, Moller P, Muller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Sturzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trumper L, Stein H, Siebert R (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419-2430 (Pubitemid 43855045)
106. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M (1986) Induction of interleukin-2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J 5:2883-2888
107. Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, Kung HJ (2009) NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J Virol 83:4435-4446
108. Jaffe ES, Krenacs L, Kumar S, Kingma DW, Raffeld M (1999) Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 111:S46-S55 (Pubitemid 29024949)
109. Jeang KT (2001) Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev 12:207-217
110. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005a) A Novel NF-{kappa}B Pathway Involving IKK{beta} and p65/RelA Ser-536 phosphorylation results in p53 inhibition in the absence of NF-{kappa}B transcriptional activity. J Biol Chem 280:10326-19332
111. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005b) Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24:6719-6728 (Pubitemid 41486802)
112. Jin D-Y, Giordano V, Kibler KV, Nakano H, Jeang K-T (1999) Role of adaptor function in oncoprotein-mediated activation of NF-κB: HTLV-I Tax interacts directly with IκB kinase γ. J Biol Chem 274:17402-17405
113. Johansson P, Jansson A, Ruetschi U, Rymo L (2009) Nuclear factor-kappaB binds to the Epstein-Barr virus LMP1 promoter and upregulates its expression. J Virol 83:1393-1401
114. Journo C, Filipe J, About F, Chevalier SA, Afonso PV, Brady JN, Flynn D, Tangy F, Israël A, Vidalain PO, Mahieux R, Weil R (2009) NRP/optineurin cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog 5:e1000521
115. Kanegane H, Yachie A, Miyawaki T, Tosato G (1998) EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma 29:491-498 (Pubitemid 28288714)
116. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663 (Pubitemid 30365393)
117. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759 (Pubitemid 41400849)
118. Katano H, Sato Y, Kurata T, Mori S, Sata T (1999) High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 155:47-52 (Pubitemid 29318701)
119. Katano H, Sato Y, Kurata T, Mori S, Sata T (2000) Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335-344 (Pubitemid 30210906)
120. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17:515-524 (Pubitemid 35223539)
121. Kellam P, Bourboulia D, Dupin N, Shotton C, Fisher C, Talbot S, Boshoff C, Weiss RA (1999) Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8. J Virol 73:5149-5155 (Pubitemid 29246778)
122. Keller SA, Schattner EJ, Cesarman E (2000) Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96:2537-2542
123. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E (2006) NF-{kappa}B is essential for progression of KSHV-and EBV-infected lymphomas in vivo. Blood 107:3295-3302
124. Kelly G, Bell A, Rickinson A (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8:1098-1104 (Pubitemid 35175964)
125. Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,-3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709-10717 (Pubitemid 41098610)
126. Kersten MJ, Van Gorp J, Pals ST, Boon F, Van Oers MH (1998) Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number. Leuk Lymphoma 30:515-524 (Pubitemid 28393686)
127. Kfoury Y, Nasr R, Favre-Bonvin A, El-Sabban M, Renault N, Giron ML, Setterblad N, Hajj HE, Chiari E, Mikati AG, Hermine O, Saib A, de Thé H, Pique C, Bazarbachi A (2008) Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene 27:1665-1676 (Pubitemid 351380258)
128. Khoshnan A, Bae D, Tindell CA, Nel AE (2000) The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28. J Immunol 165:6933-6940 (Pubitemid 32001164)
129. Kieff E (1996) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Lippincott-Raven Publishers, Philadelphia, pp 2343-2396
130. Kieser A (2008) Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. Biol Chem 389:1261-1271
131. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M (1992) Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792-1795 (Pubitemid 23087346)
132. Knowles DM (2001) Neoplastic hematopathology. Williams and Wilkins, Baltimore, p 1956
133. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552-565
134. Koga H, Imada K, Ueda M, Hishizawa M, Uchiyama T (2004) Identification of differentially expressed molecules in adult T-cell leukemia cells proliferating in vivo. Cancer Sci 95:411-417 (Pubitemid 38832684)
135. Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S, Jochmann R, Schulz TF, Erfle H, Brors B, Lausen B, Neipel F, Sturzl M (2009) A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol 83:2563-2574
136. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N (1998) Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 95:11963-11968 (Pubitemid 28460522)
137. Küppers R, Rajewsky K (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 16:471-493 (Pubitemid 28183373)
138. Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW, Greene WC (2005) Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax. J Biol Chem 280:35713-35722 (Pubitemid 41532764)
139. Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79:1296-1307 (Pubitemid 40053911)
140. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA (2002) The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16:745-754 (Pubitemid 34626694)
141. Lairmore MD, Silverman L, Ratner L (2005) Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24:6005-6015 (Pubitemid 43086118)
142. Lamsoul I, Lodewick J, Lebrun S, Brasseur R, Burny A, Gaynor RB, Bex F (2005) Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol Cell Biol 25:10391-10406 (Pubitemid 41681963)
143. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011-1099
144. Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M (2002) Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 69:119-126 (Pubitemid 34111164)
145. Lechowicz MJ, Lin L, Ambinder RF (2002) Epstein-Barr virus DNA in body fluids. Curr Opin Oncol 14:533-537
146. Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR, Chang H, Zhou FC, Gao SJ, Liang C, Jung JU (2009) FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 11:1355-1362
147. Li Y, Kang J, Horwitz M (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18:1601-1610 (Pubitemid 28100926)
148. Li H, Kobayashi M, Blonska M, You Y, Lin X (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 281:13636-13643 (Pubitemid 43855279)
149. Liebowitz D (1998) Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338:1413-1421 (Pubitemid 28221982)
150. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, Jiang RS (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350:2461-2470 (Pubitemid 38736543)
151. Liu Y, Wang Y, Yamakuchi M, Masuda S, Tokioka T, Yamaoka S, Maruyama I, Kitajima I (2001) Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene 20:2514-2526 (Pubitemid 32531348)
152. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM (2002) The human herpes virus 8 encoded viral FLICE inhibitory protein physically associates with and persistently activates the IkappaB kinase complex. J Biol Chem 5:5
153. Lo YM, Chan AT, Chan LY, Leung SF, Lam CW, Huang DP, Johnson PJ (2000) Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 60:6878-6881 (Pubitemid 32059157)
154. Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8:904-916 (Pubitemid 47622559)
155. Lu J, Lin WH, Chen SY, Longnecker R, Tsai SC, Chen CL, Tsai CH (2006) Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 281:8806-8814 (Pubitemid 43847987)
156. Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E (2003) Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc Natl Acad Sci USA 100:15595-15600 (Pubitemid 38021035)
157. Mainou BA, Everly D N Jr, Raab-Traub N (2007) Unique signaling properties of CTAR1 in LMP1-mediated transformation. J Virol 81:9680-9692 (Pubitemid 350067673)
158. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS (2008) An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27:1844-1852 (Pubitemid 351430813)
159. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue JI, Yoshida M, Taniguchi T (1987) Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343-350 (Pubitemid 18095353)
160. Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B, Chen Y, Wang D, Lin X (2005) Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 23:575-585 (Pubitemid 41779480)
161. Matsuoka M (2003) Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22:5131-5140 (Pubitemid 37059594)
162. Matsuoka M, Green PL (2009) The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 6:71
163. Matsuoka M, Jeang KT (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7:270-280 (Pubitemid 46480972)
164. Matta H, Chaudhary PM (2004) Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci USA 101:9399-9404 (Pubitemid 38812886)
165. Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary PM (2007) Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. J Biol Chem 282:24858-24865 (Pubitemid 47347558)
166. Menke DM, Chadbum A, Cesarman E, Green E, Berenson J, Said J, Tiemann M, Parwaresch R, Thome SD (2002) Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of Castleman disease at low risk for HIV infection. Am J Clin Pathol 117:268-275 (Pubitemid 34823668)
167. Merchant M, Caldwell RG, Longnecker R (2000) The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 74:9115-9124
168. Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MAS, Posnett DN, Knowles DM, Asch AS (1996) Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183:2385-2390 (Pubitemid 26158932)
169. Miller CL, Lee JH, Kieff E, Longnecker R (1994) An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci USA 91:772-776 (Pubitemid 24041484)
170. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y (1997) Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 71:314-324 (Pubitemid 26412294)
171. Moody CA, Scott RS, Amirghahari N, Nathan CA, Young LS, Dawson CW, Sixbey JW (2005) Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. J Virol 79:5499-5506 (Pubitemid 40548218)
172. Mori N, Sato H, Hayashibara T, Senba M, Hayashi T, Yamada Y, Kamihira S, Ikeda S, Yamasaki Y, Morikawa S, Tomonaga M, Geleziunas R, Yamamoto N (2002) Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood 99:1341-1349 (Pubitemid 34547090)
173. Morrison TE, Kenney SC (2004) BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology 328:219-232 (Pubitemid 39349471)
174. Morrison JA, Klingelhutz AJ, Raab-Traub N (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 77:12276-12284 (Pubitemid 37339880)
175. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, Chandran B, Nelson JA (1999) Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 73:6892-6902 (Pubitemid 29327872)
176. Nador RG, Cesarman E, Knowles DM, Said JW (1995) Herpes-like DNA sequences in a bodycavity-based lymphoma in an HIV-negative patient. N Engl J Med 333:943 (letter to the editor)
177. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 88:645-656 (Pubitemid 26240396)
178. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU (2003) Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205-4220 (Pubitemid 36350959)
179. Nasr R, Chiari E, El-Sabban M, Mahieux R, Kfoury Y, Abdulhay M, Yazbeck V, Hermine O, de The H, Pique C, Bazarbachi A (2006) Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 107:4021-4029 (Pubitemid 43726810)
180. Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, Zeichner SL (2001) Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene 20:4484-4496 (Pubitemid 32772431)
181. Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, Ross FP, Teitelbaum SL (2003) The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198:771-781 (Pubitemid 37087776)
182. Ohsugi T, Kumasaka T, Okada S, Urano T (2007) The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells. Nat Med 13:527-528 (Pubitemid 46828469)
183. Okamoto K, Fujisawa J, Reth M, Yonehara S (2006) Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB. Genes Cells 11:177-191
184. Panagopoulos D, Victoratos P, Alexiou M, Kollias G, Mosialos G (2004) Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. J Virol 78:13253-13261 (Pubitemid 39507830)
185. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044
186. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 151:1517-1522 (Pubitemid 27527913)
187. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y (2000) Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743-749 (Pubitemid 30626930)
188. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N (1995) Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146:1355-1367
189. Peloponese JM, Yeung ML, Jeang KT (2006) Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 34:1-12 (Pubitemid 43780373)
190. Peloponese JJ, Yasunaga J, Kinjo T, Watashi K, Jeang KT (2009) Peptidylproline cis-transisomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J Virol 83:3238-3248
191. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2:269-276 (Pubitemid 41131008)
192. Pise-Masison CA, Brady JN (2005) Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function. Front Biosci 10:919-930
193. Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN (1998) Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol 72:1165-1170 (Pubitemid 28116899)
194. Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN (2002) Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 62:3562-3571 (Pubitemid 34651409)
195. Poiesz BF, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of a type C retrovirus particles from fresh cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419 (Pubitemid 11131140)
196. Pomerantz JL, Baltimore D (2002) Two pathways to NF-kappaB. Mol Cell 10:693-695
197. Portis T, Harding JC, Ratner L (2001) The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 98:1200-1208
198. Pozzatti R, Vogel J, Jay G (1990) The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 10:413-417
199. Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G, Samaniego F (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst 94:926-935 (Pubitemid 34778091)
200. Prince S, Keating S, Fielding C, Brennan P, Floettmann E, Rowe M (2003) Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J Virol 77:5000-5007 (Pubitemid 36402850)
201. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF (1997) The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915-5921 (Pubitemid 27304928)
202. Raphaël M, Said J, Borisch B, Cesarman E, Harris NL (2008) Lymphomas associated with HIV infection. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 340-342
203. Rappocciolo G, Hensler HR, Jais M, Reinhart TA, Pegu A, Jenkins FJ, Rinaldo CR (2008) Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol 82:4793-4806 (Pubitemid 351657041)
204. Rauch D, Gross S, Harding J, Niewiesk S, Lairmore M, Piwnica-Worms D, Ratner L (2009) Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood 113:1493-1500
205. Reed JA, Nador RG, Spaulding D, Tani Y, Cesarman E, Knowles DM (1998) Demonstration of Kaposi's sarcoma-associated herpesvirus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 91:3825-3832 (Pubitemid 28225751)
206. Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN (1993) Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 8:3029-3036 (Pubitemid 23312907)
207. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2:342-346 (Pubitemid 26080656)
208. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Héon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295:1077-1079 (Pubitemid 34132238)
209. Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Lippincott-Raven Publishers, Philadelphia, pp 2397-2446
210. Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y (2001) Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 J Virol 75:429-438
211. Robek MD, Ratner L (1999) Immortalization of CD4 (+) and CD8 (+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73:4856-4865 (Pubitemid 29246746)
212. Rochford R, Miller CL, Cannon MJ, Izumi KM, Kieff E, Longnecker R (1997) In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2). Arch Virol 142:707-720 (Pubitemid 27185677)
213. Sadagopan S, Sharma-Walia N, Veettil MV, Raghu H, Sivakumar R, Bottero V, Chandran B (2007) Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J Virol 81:3949-3968 (Pubitemid 46586891)
214. Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D (1999) A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73:5722-5730 (Pubitemid 29274858)
215. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP (1996) Primary effusion lymphoma in women: report of two cases of Kaposi's sarcomaherpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 88:3124-3128 (Pubitemid 26357396)
216. Saitoh Y, Yamamoto N, Dewan MZ, Sugimoto H, Martinez Bruyn VJ, Iwasaki Y, Matsubara K, Qi X, Saitoh T, Imoto I, Inazawa J, Utsunomiya A, Watanabe T, Masuda T, Yamamoto N, Yamaoka S (2008) Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 111:5118-5129
217. Samaniego F, Pati S, Karp JE, Prakash O, Bose D (2001) Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr (28): 15-23
218. Samols MA, Hu J, Skalsky RL, Renne R (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79:9301-9305 (Pubitemid 40934841)
219. Sanda T, Asamitsu K, Ogura H, Iida S, Utsunomiya A, Ueda R, Okamoto T (2006) Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 20:590-598
220. Sarid R, Wiezorek JS, Moore PS, Chang Y (1999) Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 73:1438-1446 (Pubitemid 29036799)
221. Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y, Okayama A, Hamada K, Okabe H, Murakami Y, Tsubouchi H, Morishita K (2005) Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105:1204-1213 (Pubitemid 40170895)
222. Satou Y, Yasunaga J, Yoshida M, Matsuoka M (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 103:720-725 (Pubitemid 43153092)
223. Senftleben U, Cao Y, Xiao G, Kraehn G, Greten F, Chen Y, Hu Y, Fong A, Sun S-C, Karin M (2001) Activation of IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293:1495-1499 (Pubitemid 32801552)
224. Seo T, Park J, Lim C, Choe J (2004) Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus. Oncogene 23:6146-6155 (Pubitemid 39178867)
225. Sgarbanti M, Arguello M, ten Oever BR, Battistini A, Lin R, Hiscott J (2004) A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene 23:5770-5780 (Pubitemid 39093022)
226. Shembade N, Harhaj NS, Liebl DJ, Harhaj EW (2007a) Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1-and LPS-mediated NF-kappaB and JNK signaling. EMBO J 26:3910-3922 (Pubitemid 47367492)
227. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW (2007b) The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J Virol 81:13735-13742 (Pubitemid 350247866)
228. Shembade N, Harhaj NS, Parvatiyar K, Copeland NG, Jenkins NA, Matesic LE, Harhaj EW (2008) The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol 9:254-262 (Pubitemid 351276830)
229. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC (1987) Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus type 1. Proc Natl Acad Sci USA 84:5389-5393 (Pubitemid 17119126)
230. Sinfield RL, Molyneux EM, Banda K, Borgstein E, Broadhead R, Hesseling P, Newton R, Casabonne D, Mkandawire N, Nkume H, Hodgson T, Liomba G (2007) Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998-2003. Pediatr Blood Cancer 48:515-520 (Pubitemid 46496345)
231. Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C (2004) Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood 104:2523-2531 (Pubitemid 39331856)
232. Skaug B, Jiang X, Chen ZJ (2009) The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78:769-796
233. Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-Garcia ME, Ovechkina YL, Rawlings DJ (2005) Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity 23:561-567
234. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay M-F, Clauvel J-P, Raphael M, Degos L, Sigaux F (1995) Kaposi's sarcoma-associated herpesviruslike DNA sequences in multicentric Castleman's disease. Blood 86:1275-1280
235. Speck P, Kline KA, Cheresh P, Longnecker R (1999) Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol 80(Pt 8):2193-2203 (Pubitemid 29389158)
236. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT (1999) Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73:4181-4187 (Pubitemid 29189863)
237. Stewart S, Dawson CW, Takada K, Curnow J, Moody CA, Sixbey JW, Young LS (2004) Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci USA 101:15730-15735 (Pubitemid 39473556)
238. Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B (1999) Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 91:1725-1733 (Pubitemid 29518767)
239. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, Humphries LA, Kato RM, Kang S, Patrone L, Wall R, Teitell M, Leitges M, Kawakami T, Rawlings DJ (2002) PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3:780-786
240. Suda T, Katano H, Delsol G, Kakiuchi C, Nakamura T, Shiota M, Sata T, Higashihara M, Mori S (2001) HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathol Int 51:671-679 (Pubitemid 32989612)
241. Sugano N, Chen W, Roberts ML, Cooper NR (1997) Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction. J Exp Med 186:731-737 (Pubitemid 27381537)
242. Sun SC (2010) CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation. Cell Death Differ 17(1):25-34
243. Sun SC, Ballard DW (1999) Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases. Oncogene 18:6948-6958
244. Sun SC, Ley SC (2008) New insights into NF-kappaB regulation and function. Trends Immunol 29:469-478
245. Sun CC, Thorley-Lawson DA (2007) Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol 81:13566-13577 (Pubitemid 350247850)
246. Sun SC, Xiao G (2003) Deregulation of NF-kB and its upstream kinases in cancer. Cancer Metastasis Rev 22:405-422 (Pubitemid 36791896)
247. Sun SC, Yamaoka S (2005) Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene 24:5952-5964 (Pubitemid 43086113)
248. Sun L, Deng L, Ea C-K, Xia Z-P, Chen ZJ (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14:289-301 (Pubitemid 38591401)
249. Suzuki T, Fujisawa JI, Toita M, Yoshida M (1993) The trans-activator tax of human T-cell leukemia virus type I (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 90:610-614 (Pubitemid 23028913)
250. Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R (2005) Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol 79:7355-7362 (Pubitemid 40756771)
251. Swanson-Mungerson M, Bultema R, Longnecker R (2006) Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol 80:6764-6770 (Pubitemid 44025176)
252. Swart R, Ruf IK, Sample J, Longnecker R (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74:10838-10845
253. Takatsuki K (2005) Discovery of adult T-cell leukemia. Retrovirology 2:16
254. Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G (2000) p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14 (ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. Blood 95:3939-3944 (Pubitemid 30412871)
255. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M (1990) Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87:1071-1075
256. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF (1998) Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91:1373-1381 (Pubitemid 28086891)
257. Taylor GP, Matsuoka M (2005) Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24:6047-6057 (Pubitemid 43086122)
258. Taylor JM, Nicot C (2008) HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13:733-747
259. Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1:75-82 (Pubitemid 33741978)
260. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328-1337 (Pubitemid 38375368)
261. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, Hiraki A, Nakayama H, Shibuya A, Ma Y, Kawabata T, Okada S, Harada M (1998) Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Blood 92:1374-1383 (Pubitemid 28369051)
262. Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G, Iwanaga Y, Yamamoto N, Ohtani K, Nakamura M, Fujii M (1999) Induction of Bcl-x (L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol 73:7981-7987 (Pubitemid 29441656)
263. Tsukasaki K, Tanosaki S, DeVos S, Hofmann WK, Wachsman W, Gombart AF, Krebs J, Jauch A, Bartram CR, Nagai K, Tomonaga M, Said JW, Koeffler HP (2004) Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. Int J Cancer 109:875-881 (Pubitemid 38500744)
264. Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M, Sun S-C (1998) NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J Biol Chem 273:21132-21136 (Pubitemid 28385401)
265. Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, Maia SP, Shao J, Arrand JR, Young LS, O'Neil JD (2010) Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappa-B pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol Cancer 9:1
266. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693-733
267. Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7:266-281 (Pubitemid 46414075)
268. Wada K, Niida M, Tanaka M, Kamitani T (2009) Ro52-mediated monoubiquitination of IKK{beta} downregulates NF-{kappa}B signaling. J Biochem 146:821-832
269. Wäldele K, Silbermann K, Schneider G, Ruckes T, Cullen BR, Grassmann R (2006) Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 107:4491-4499 (Pubitemid 43801377)
270. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
271. Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM, Clarke SH (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177:2793-2802 (Pubitemid 44277794)
272. Wu X, Sun SC (2007) Retroviral oncoprotein Tax deregulates NF-kB by activating Tak1 and mediating Tak1-IKK physical association. EMBO Rep 8:510-515 (Pubitemid 46696523)
273. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat Cell Biol 8:398-406
274. Xiao G, Sun SC (2000) Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. Oncogene 19:5198-5203
275. Xiao G, Harhaj EW, Sun S-C (2000) Domain-specific interaction with IKKγ is an essential step in Tax-mediated activation of IKK. J Biol Chem 275:34060-34067
276. Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M, Sun SC (2001a) Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J 20:6805-6815 (Pubitemid 33134210)
277. Xiao G, Harhaj EW, Sun SC (2001b) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7:401-409 (Pubitemid 32206507)
278. Xiao G, Fong A, Sun SC (2004) Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem 279:30099-30105 (Pubitemid 38937932)
279. Xie P, Hostager BS, Bishop GA (2004) Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J Exp Med 199:661-671 (Pubitemid 38316433)
280. Yasunaga J, Matsuoka M (2007) Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control 14:133-140 (Pubitemid 46515149)
281. Yin M-J, Christerson LB, Yamamoto Y, Kwak Y-T, Xu S, Mercurio F, Barbose M, Cobb MH, Gaynor RB (1998) HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93:875-884 (Pubitemid 28257592)
282. Yoshida M (2001) Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475-496 (Pubitemid 32368043)
283. Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031-2035 (Pubitemid 12088563)
284. Yoshimi R, Chang TH, Wang H, Atsumi T, Morse HC 3rd, Ozato K (2009) Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J Immunol 182:7527-7538
285. Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12:421-429 (Pubitemid 35370755)
286. Yu Q, Minoda Y, Yoshida R, Yoshida H, Iha H, Kobayashi T, Yoshimura A, Takaesu G (2008) HTLV-1 Tax-mediated TAK1 activation involves TAB 2 adapter protein. Biochem Biophys Res Commun 365:189-194 (Pubitemid 350110575)
287. Zhao LJ, Giam CZ (1991) Interaction of T-cell lymphotropic virus type I (HTLV-1) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-1 enhancer. Proc Natl Acad Sci USA 88:11445-11449
288. Zhao LJ, Giam CZ (1992) Human T-cell lymphotropic virus type I (HTLV-1) transcriptional activator, Tax, enhances CREB binding to HTLV-1 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 89:7070-7474
289. Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M (2009) Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood 113:2755-2764
290. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM (2004) Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427:167-171 (Pubitemid 38094958)